Medrad, Inc. Sustainability Profile
Medrad, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 1970, the company has established itself as a leader in the development of innovative imaging solutions, particularly in the fields of radiology and interventional procedures. With a strong presence in North America and expanding operations globally, Medrad is renowned for its advanced contrast delivery systems and automated injector technologies. These products enhance diagnostic accuracy and patient safety, setting the company apart in a competitive market. Medrad's commitment to quality and innovation has earned it a significant market position, with numerous accolades recognising its contributions to healthcare. As a trusted partner for healthcare providers, Medrad continues to shape the future of medical imaging with its cutting-edge solutions.
DitchCarbon Score
How does Medrad, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medrad, Inc.'s score of 93 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medrad, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of available figures. The company is a merged entity, and its emissions performance data is inherited from Bayer HealthCare AG, which is the source organization for any relevant climate performance metrics. As of now, Medrad, Inc. has not established specific reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate initiatives. This lack of defined targets suggests that the company may still be in the early stages of formalising its climate strategy. In the context of the industry, it is essential for companies like Medrad, Inc. to develop and communicate clear climate commitments to align with global sustainability goals and enhance their environmental accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 1,215 | 0,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Medrad, Inc.'s Industry?
How Carbon Intensive is Medrad, Inc.'s Location?
Medrad, Inc.'s Scope 3 Categories Breakdown
Medrad, Inc.'s Scope 3 emissions, which decreased by 16% last year and increased significantly since 2004, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Top Scope 3 Categories
Medrad, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medrad, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
